Olmesartan Medoxomil/Amlodipine/Hydrochlorothiazide Clonmel (Olmesartan Medoxomil, Amlodipine, Hydrochlorothiazide)

Olmesartan medoxil, the active ingredient in Olmesartan Medoxomil/Amlodipine/Hydrochlorothiazide Clonmel, is a combination antihypertensive presented as a tablet for oral use. It treats high blood pressure in adults, often when single‑agent therapy is insufficient.

GNH USA supplies Olmesartan Medoxil/Amlodipine/Hydrochlorothiazide Clonmel as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Olmesartan Medoxil/Amlodipine/Hydrochlorothiazide Clonmel is used in the management of hypertension, acting on the renin‑angiotensin system and vascular smooth‑muscle tone. - Essential hypertension: lowers systolic and diastolic blood pressure when monotherapy does not achieve target levels. - Hypertension with fluid retention: provides additional diuretic effect to reduce peripheral edema. - Hypertension in patients requiring multiple mechanisms: combines an ARB, calcium‑channel blocker and thiazide diuretic for synergistic control.

Adverse reactions may range from mild to severe and should be monitored during therapy.

Common Side Effects: - Dizziness or light‑headedness - Peripheral edema - Headache - Fatigue - Cough - Increased urination

Serious or Rare Side Effects: - Hyperkalemia or electrolyte imbalance - Acute kidney injury - Severe hypotension - Angio‑edema - Liver function abnormalities - Blood cell count changes

Before initiating therapy, clinicians should assess patient history and monitor relevant parameters. - Renal function: evaluate creatinine clearance and adjust if necessary. - Electrolytes: monitor potassium and sodium levels regularly. - Cardiovascular status: watch for symptomatic hypotension, especially after the first dose. - Pregnancy: avoid use; teratogenic risk is present. - Concomitant drugs: review for interactions that affect blood pressure or renal function. - Store at ambient temperature: keep below 25°C, retain original packaging, protect from moisture and direct sunlight.

Olmesartan Medoxil/Amlodipine/Hydrochlorothiazide Clonmel can interact with several drug classes; careful review is essential.

Major Interactions (Avoid): - Potassium‑rich supplements or potassium‑sparing diuretics: risk of hyperkalemia. - Strong CYP3A4 inhibitors (e.g., clarithromycin, itraconazole): increase amlodipine exposure. - NSAIDs (high dose): may blunt antihypertensive effect and impair renal function.

Moderate Interactions (Monitor Closely): - Lithium: may increase serum lithium levels. - ACE inhibitors or other ARBs: additive effect on potassium and renal function. - Antidiabetic agents: may require dose adjustment due to enhanced glucose lowering.